High Tower Advisors, LLC Ocular Therapeutix, Inc Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
BUY
$3.85 - $10.93 $6,275 - $17,815
1,630 Added 10.1%
17,768 $161,000
Q4 2023

Feb 12, 2024
SELL
$2.08 - $4.52 $8,320 - $18,080
-4,000 Reduced 19.86%
16,138 $71,000
Q3 2023

Nov 08, 2023
SELL
$3.14 - $5.04 $1,884 - $3,024
-600 Reduced 2.89%
20,138 $63,000
Q2 2023

Aug 14, 2023
SELL
$4.6 - $7.64 $1,517 - $2,521
-330 Reduced 1.57%
20,738 $107,000
Q4 2022

Feb 08, 2023
SELL
$2.61 - $4.41 $1,827 - $3,087
-700 Reduced 3.22%
21,068 $59,000
Q1 2022

May 12, 2022
BUY
$4.83 - $7.35 $12,075 - $18,375
2,500 Added 12.97%
21,768 $108,000
Q4 2021

Feb 10, 2022
BUY
$6.16 - $12.07 $40,040 - $78,455
6,500 Added 50.91%
19,268 $134,000
Q3 2021

Nov 12, 2021
BUY
$9.7 - $14.34 $24,250 - $35,850
2,500 Added 24.35%
12,768 $128,000
Q2 2021

Aug 06, 2021
SELL
$13.43 - $19.16 $13,644 - $19,466
-1,016 Reduced 9.0%
10,268 $146,000
Q1 2021

May 10, 2021
SELL
$15.82 - $22.11 $21,768 - $30,423
-1,376 Reduced 10.87%
11,284 $185,000
Q4 2020

Feb 10, 2021
BUY
$7.91 - $22.95 $100,140 - $290,547
12,660 New
12,660 $261,000
Q3 2020

Nov 13, 2020
SELL
$7.36 - $9.87 $703,903 - $943,956
-95,639 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$4.67 - $8.95 $446,634 - $855,969
95,639 New
95,639 $790,000

Others Institutions Holding OCUL

# of Institutions
171
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email